Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output
published in: Journal of the American Medical Association
date of publication: 2012-03-01
language: English
main subject: hereditary hemorrhagic telangiectasia, patient, bevacizumab
Cites articles
There is nothing here
Article - wd:Q34031011